To mark his installation as the Philip Hallen Endowed Chair in Community Health and Social Justice, BCHS’s STEVEN ALBERT will revisit Rousseau’s 1754 Discourse on the Origin and Foundations of Inequality Among Men , or “Second Discourse.” We have moved beyond early philosophical speculation to an emerging science of inequality, where the emergence of hierarchy can be explored experimentally. Health disparities can be viewed through this same len...
A new way to collect and organize data could be the answer to tackling the years-long opioid overdose epidemic. The University of Pittsburgh’s Program Evaluation and Research Unit (PERU) is working with Pennsylvania officials to standardize death data from overdose victims. The purpose of the project is to provide more detailed reporting in real-time that could help show where the problem areas are. A large number of staffers are Pitt Public Heal...
CNBC - New California legislation prompts Nightly Business Report ’s Meg Tirrell to ask HPM’s WALLID GELLAD about California Governor Brown’s bill requiring pharma to announce 60 days before a rise of more than 16 percent over two years, and to provide justification for the hike. Locate Gellad’s comments at 17:37–18:05.
TIME MAGAZINE - Granting top honors to Pittsburgh's East Liberty & Lawrenceville neighborhoods, Time's MONEY rankings cite the steel town's reinvigorated cool factor and influx of new bars, restaurants, and hotels. They signal out the Ace Hotel (and cool bar), housed in a former YMCA where guests can play cornhole, ping pong, and video games in the old-school gym.
CNN - Despite any advantages Xtampza may have (harder to crush and abuse), “people still get addicted to oral pills. They can still take too much. They can still overdose,” said HPM’s WALLID GELLAD, co-director of the University of Pittsburgh’s Center for Pharmaceutical Policy and Prescribing. Gellad believes that there'’s more to Cigna’s new policies than a desire to combat the opioid crisis.
It is known that high blood pressure in one’s 50s puts a person at risk for dementia in later life. It's now know that hypertension in the 30s and 40s has a similar effect, but only in women. LEWIS KULLER, epidemiology professor emeritus, talks about why this unexpected research finding might be true.
On Tuesday, October 3, 2017, EMMA HOSMAN, MPH candidate in BCHS, presented her work from the Pittsburgh Summer Institute with the Allegheny County Health Department at the PA Governor’s Emergency Preparedness Summit. The conference was in Hershey, Pa., and was attended by preparedness professionals from throughout the commonwealth.
This September, the Department of Infectious Diseases and Microbiology recognized student research poster winners at the annual IDM research day. Students winners were awarded prizes in various categories during the next day's IDM annual meeting and picnic at North Park.
Congratulations to alumnus CHARLES JOHN SCHLEUPNER (IDM ’68), who has been appointed to the Dean’s Council on Advancement for the Virginia Tech Carilion School of Medicine. The council is a committee of volunteers created to advance the stature of the medical school by providing guidance, assistance, advocacy, and philanthropic investment in support of the school’s strategic objectives.
AMERICAN JOURNAL OF MANAGED CARE - An article by alumna INMACULADA (INMA) HERNANDEZ (HPM ’16) discusses the impact of the outcomes-based pricing arrangements proposed by Amgen on the pricing of PCSK9 inhibitor therapy, and provides recommendations for payers on the design of outcomes-based contracts. She is an assistant professor at Pitt’s School of Pharmacy. Her research explores the intersection of pharmaceutical health services and outcomes re...
Researcher SUZANNE GOLLIN, Department of Human Genetics, has been reappointed as a member of the Pennsylvania Cancer Control, Prevention, and Research Advisory Board. This was confirmed by the Senate on September 20, 2017. She is pictured here with an image of tumor cell biomarkers.
WALL STREET JOURNAL - One of the largest managers of pharmaceutical benefits in the U.S. says it will start limiting the duration and dose of some prescriptions for opioid painkillers, in an effort to combat widespread addiction. The restrictions, based on CDC recommendations published last year, could cause some debate. WALID GELLAD, physician and HPM assistant professor, said the restrictions for chronic pain could cause cumbersome paperwork an...
Alumnus DAVID SALCIDO (EPI ’08) was guest lecturer for the September 21, 2017, epidemiology seminar with a talk titled “Cardiac Arrest, Resuscitation and the Opioid Epidemic.” He began his resuscitation research work in 2006. Since then he has developed interests in cardiac arrest physiology (acute phase), resuscitation device and robotics development, signal analysis, and emergency medicine epidemiology.
CHARLOTTE BUSINESS JOURNAL - After a natioinwide search, NC-based Carolinas HealthCare System has tapped alumnus ANTHONY DEFURIO (HADM ’89) to serve as executive vice president and CFO, effective October 2017. Carolinas recently announced it would merge with Chapel Hill-based UNC Health Care, forming one of the nation’s largest hospital networks. Leading up to this new position, DeFurio was senior vice president and CFO at University of Colorado ...
CURBED - Look at the stats! In addition to a raft of articles talking about the city’s growing tech sector, a new report from the Brookings Institution just found that Pittsburgh’s per capita university research and development (R&D) spending was nearly two and a half times the national average, and its millennial population has risen 37.3 percent between 2000 and 2013.
PITTSBURGH COURIER - Nearly half of all African American adults have some form of cardiovascular disease, and African Americans have nearly twice the risk for a first-ever stroke than Caucasians, resulting in a much higher death rate from stroke. Alumnus MARIO BROWNE (BCHS ’05), Pitt’s director of health sciences diversity and a spokesperson for the American Heart Association, talks about how those diseases can be prevented.
WTAE ACTION NEWS - As the opioid crisis sweeping the country, demand for naloxone has soared—and so has the price. HPM’s WALID GELLAD, who studies drug pricing, says the system is completely out of control. Naloxone cost increases have sky-rocketed, a huge concern for emergency service providers and community organizations.
WIRED - Researchers have been calling for this kind of data-driven approach to the national opioid epidemic. They want to study the spread of opioids like infectious diseases, by looking at transmission patterns and recovery rates. But much of the data is locked in state agencies, making it difficult to access, says DONALD BURKE, dean of the Graduate School of Public Health at University of Pittsburgh. “These data should be liberated,” he says.
BCHS rock star MARTHA TERRY is also amazing outside the classroom. Last weekend she was busy with community work in Pittsburgh’s Friendship neighborhood.
Drug policy researcher WALID GELLAD says the outcomes-based contracts are being viewed as the solution to the drug-price problem, and they’re not going to be, at least not in the short term. The deals don’t stop drug companies from charging high starting prices for new drugs or from steadily raising prices for older drugs. Any rebates or discounts in outcomes-based contracts are off an already inflated number. He favors other ways to curb drug co...